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OBJECTIVE To validate the Greek translation of the Cognitive Disorders Ex-
amination (Codex) and to investigate its potential for implementation for the 
detection of dementia in the Greek population. METHOD Subjects aged ≥60 
years with and without dementia, based on the diagnostic criteria DSM-IV-TR, 
were included in the study. Translation of the test Codex from French to Greek 
and back-translation from Greek to French were conducted to verify the validity 
of the translation. The Greek version of the Codex and the Mini Mental State 
Examination (MMSE) were administered to 17 patients with dementia and 27 
patients without dementia. RESULTS The median age of the participants was 
82 years (range 61–93 years) for patients with dementia and 73 years (range 
61–84 years) for patients without dementia. The average level of education 
was 9.0 years (range 2–20 years) for patients with dementia and 10.5 years 
(range 3–16 years) for those without. The average score on the MMSE was 
15.7 (range 7–27) for patients with dementia and 28.3 (range 25–30) for those 
without dementia. The sensitivity of Codex for the detection of dementia 
was 94.1% and its specificity was 88.9%. CONCLUSIONS The Greek version of 
Codex can detect dementia reliably. Its validation as a diagnostic tool for use 
in the Greek population will require testing on a larger sample of individuals.
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Dementia is a major problem in later life and has a sig-
nificant social impact both in Greece and worldwide. The 
prevalence of dementia is constantly increasing, given that 
life expectancy is raising and the prevalence of dementia 
increases with age. It has been estimated that the number 
of people who suffer from dementia doubles every 20 years 
and will reach 81 million in 2040.1 
According to data available from Alzheimer Europe, the 
mean prevalence of dementia in the European Union (EU-
28) in 2012 was estimated to be 1.55%, which is equivalent 
to 8,702,033 cases. This estimation was based on the number 
of diagnosed cases of dementia, but as many patients with 
dementia have not received a formal diagnosis the real 
prevalence may be much higher. In Greece, it is estimated 
that 1.77% of the general population suffers from demen-
tia, equivalent to 201,766 people. According to Alzheimer 
Hellas, it is believed that around 50,000 people in Greece 
are living with dementia that has not been diagnosed.2 
Subjective memory complaints are very common in 
older people, but this does not necessarily mean that there 
is a cognitive decline, as shown by objective neuropsycho-
logical tests. In some cases, there may be an underlying 
cognitive dysfunction in the form of mild cognitive impair-
ment (MCI), which is often a prodrome of dementia. In other 
cases, the person may suffer from depression or anxiety 
disorder with cognitive symptoms. Evidence of memory loss 
is one of the conditions for diagnosing dementia, but this 
alone is not enough. In addition to memory decline there 
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needs to be at least one of the following four character-
istics: Language disturbance, impaired ability to carry out 
motor activities, failure to identify objects, disturbance in 
executive functioning. Reversible physical causes or other 
mental illnesses need to be excluded. The criteria for the 
diagnosis of dementia are presented in table 1.3 The most 
common cause of dementia is Alzheimer’s disease (AD), 
followed in decreasing frequency by vascular dementia, 
dementia with Lewy bodies, frontotemporal dementia and 
other rarer forms of dementia.
Among the tools used for diagnosing dementia, the 
most popular is the Mini Mental State Examination (MMSE),4 
which has been validated in Greek.5 The MMSE consists of 
30 questions covering orientation, learning, attention and 
calculation, recall of three words, language, triple command 
and copying. A score of below 24 indicates the presence 
of cognitive disorder. The main disadvantage of MMSE is 
that the outcome is dependent on the educational level 
of the individual, and in addition it is subject to cultural 
differences. As an example of its limitations, individuals 
of a higher educational level may need more detailed 
neuropsychological assessment to reveal mild cognitive 
decline. Conversely, individuals of a lower educational level 
may have difficulty in completing some of its components, 
without this meaning that they have a cognitive deficit. 
Moreover, its duration (approximately 10–15 minutes) is 
often a barrier to its implementation in the primary care 
setting. 
Another popular tool for the assessment of cognitive 
functions is the Montreal Cognitive Assessment (MoCA),6 
which has also been translated into Greek.7 The basic ad-
vantages of MoCA over MMSE are that it can be used with 
people of a lower educational level and it is very sensitive 
in detecting MCI and AD at an early stage.
Other tests that are used for the detection of dementia 
in primary care are the Clock Drawing Test (CDT),8 for which 
there is a variety of scoring systems,9 Mini Cog,10 General 
Practitioner Assessment of Cognition (GPCOG),11 which has 
been translated into Greek,12 Test Your Memory (TYM),13 that 
has been validated in Greek,14 and others.
More specific tests are available for the investigation of 
cognitive functions, but these require more time and are 
usually administered in the context of neuropsychological 
assessment in memory clinics. Examples are CAMDEX,15 
which has been translated into Greek,16 and Addenbrooke’s 
Cognitive Examination,17 and there are many other tools. 
In 2007 Belmin and colleagues developed an ultra-rapid 
test for the detection of dementia, which they named 
Cognitive Disorders Examination (Codex). Codex consists 
of 3-word recall and a simplified Clock Drawing Test (sCDT) 
as the first step. If the individual does not perform correctly 
in one of the two components of the first step, then we 
proceed to the second step, which includes 5 questions 
of orientation in space. Codex consists of a decision tree 
which stratifies patients in four diagnostic categories based 
on the probability of dementia. The validation of Codex in 
France was conducted in a population of patients attending 
a memory clinic for consultation because of a subjective 
memory complaint. Its initial development was based on 
data from 242 individuals (derivation study) and it was 
subsequently validated in 323 individuals (validation study). 
The sensitivity of the test was 93% and its specificity 85%.18 
The objective of the present study was to validate the 
translation of Codex into the Greek language and to explore 
its potential for implementation in the Greek population.
Table 1. Diagnostic criteria for dementia of the Alzheimer type (DSM-
IV-TR).3
A. The development of multiple cognitive deficits manifested by both:
 1. Memory impairment (impaired ability to learn new information 
or to recall previously learned information)
 2. One (or more) of the following cognitive disturbances:
  a. Aphasia (language disturbance)
  b. Apraxia (impaired ability to carry out motor activities despite 
intact motor function)
  c. Agnosia (failure to recognize or identify objects despite intact 
sensory function)
  d. Disturbance in executive functioning (i.e., planning, organizing, 
sequencing, abstracting)
B. The cognitive deficits in criteria A1 and A2 each cause significant 
impairment in social or occupational functioning, and represent a 
significant decline from a previous level of functioning
C. The course is characterized by gradual onset and continuing 
cognitive decline
D. The cognitive deficits in criteria A1 and A2 are not due to any of the 
following:
 1. Other central nervous system conditions that cause progressive 
deficits in memory and cognition (e.g., cerebrovascular disease, 
Parkinson disease, Huntington disease, subdural hematoma, 
normal-pressure hydrocephalus, brain tumor)
 2. Systemic conditions that are known to cause dementia (e.g., 
hypothyroidism, vitamin B12 or folic acid deficiency, niacin 
deficiency, hypercalcemia, neurosyphilis, HIV infection)
 3. Substance-induced conditions
E. The deficits do not occur exclusively during the course of a delirium
F. The disturbance is not better accounted for by another axis I 
disorder (e.g., major depressive disorder, schizophrenia)
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MATERIAL AND METHOD 
Translation of Codex
Codex was first translated from French to Greek by C.A. after 
which a back-translation of the test from Greek to French was made 
by E.S.K. The back-translation was then checked by J.B., who is the 
creator of the original test in French. The Greek version of Codex 
and the decision tree are presented in Appendix 1 and Appendix 2. 
Description of Codex
Codex consists of two steps, the second being conditional on 
the outcome of the first step. The first step includes two tests, a 
3-word recall and a sCDT. First we ask the individual to repeat and 
keep in mind three simple words pronounced by the examiner, 
without scoring at this point. We then give the person a piece of 
paper on which is printed a circle 10 cm in diameter and ask the 
individual to draw the numbers of a clock face. We ask the indi-
vidual to draw the clock hands to represent exactly the specific 
time requested (noted for later assessment). For the performance 
on the test to be considered normal at this step, the following 
conditions need to be fulfilled: The numbers are all present, their 
positions is correct, the direction of the hands shows approximately 
the time requested and we can distinguish the shorter from the 
longer hand. If one or more of these conditions are not met, then 
we consider the clock drawing test to be abnormal. 
We subsequently ask the individual to recall the three words 
that were said to them earlier. This item is scored as normal if the 
patient remembers all three words. If both the 3-word recall and 
the sCDT are correct, the test Codex is ended and the person is 
classified in category Codex A, which is associated with a very low 
probability of dementia (6%). If both items of the first step are 
abnormal, the test Codex is also ended, but the patient is classified 
in category Codex D, which is related to a very high probability 
of dementia (92%). 
If the result of one of the items of the first step is normal and 
the other is abnormal, we proceed to the second step. The second 
step includes 5 questions of orientation in space (see Appendix 
1). Each correct answer is given 1 point, so that the overall score 
in this step may range from 0 to 5. If the score of the second step 
is 4 or 5, the person is classified in category Codex B, which is as-
sociated with low to moderate probability of dementia (23%). If 
the score is 0–3, the person is classified in category Codex C, which 
is related to a high probability of dementia (71%). 
In general, categories A and B are considered to represent a 
negative result for dementia, indicating the need for investigation 
of alternative diagnoses. Categories C and D represent a positive 
result for dementia, and the patient should be referred to a spe-
cialist in dementia.
Study population
The study population included patients from the following 
settings:
(a) Patients attending the Neochori general practice, belonging to 
the Health Center of Argalasti in Magnesia, for chronic disease 
management or routine medical prescription.
(b) Patients attending the Unit for the Management of Alzheimer’s 
Disease and Associated Disorders in Volos for examination by 
a psychologist due to of reported memory loss. These patients 
underwent complete neuropsychological assessment. 
(c) Patients with a diagnosis of dementia who attended the Day 
Center of the Unit for the Management of Alzheimer’s Disease 
and Associated Disorders in Volos to participate in various 
group activities.
All the participants were aged ≥60 years and all could see, 
hear and read (patients who could not read and those with severe 
visual or hearing impairment were excluded from the study). All 
patients gave their consent for inclusion in the study.
Methodology
All the participants were administered first Codex and then 
MMSE. The examination with these two tools was performed in such 
a way that the administration of Codex did not interfere with the 
administration of MMSE. Specifically, during the administration of 
Codex, for the 3-word recall we used the same three words which 
are used in MMSE, and during the subsequent administration of 
MMSE we used the score obtained earlier without repeating the 
3-word recall test.
Basic demographic data (age, sex, and years of education) were 
recorded for all participants, who were divided into two groups: 
These who had dementia based on the diagnostic criteria DSM-
IV-TR and those who did not have dementia (referred to as the 
control group or patients without dementia). The findings from 
the examination with Codex and MMSE were correlated with the 
clinical diagnosis (dementia or not) and the sensitivity, specific-
ity, positive predictive value and negative predictive value of the 
Greek version of Codex were estimated.
Statistical analysis 
Statistical analysis of the results was performed with the soft-
ware Statistical Package for Social Sciences (IBM SPSS Statistics), 
version 22.0. Comparison among percentages was made with 
Pearson’s chi square (x²) test, and among continuous variables with 
the independent samples t-test. The results on Codex and MMSE 
were compared and the sensitivity, specificity, positive predictive 
value and negative predictive value of the Greek version of Codex 
were calculated. 
RESULTS
In total, 44 patients participated in the study, among 
whom 17 had dementia based on DSM-IV-TR diagnostic 
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criteria, and 27 did not have dementia. The median age 
of the patients with dementia was 82 years (range 61–93 
years). In this group there were 13 women (76.5%) and 4 
men (23.5%) and the mean level of education was 9 years 
(range 2–20 years). The mean MMSE score of the group 
with dementia was 15.7 (range 7–27).
In the group of patients without dementia, the median 
age was 73 years (range 61–84 years). There were 16 women 
(59.3%) and 11 men (40.7%) with a mean level of education 
of 10.5 (range 3–16 years). Their mean MMSE score was 28.3 
(range 25–30). Among the patients without dementia, 17 
(63%) reported a subjective memory decline when they 
were asked specifically, while the remaining 10 (37%) did 
not have any subjective memory complaint.
In both groups of patients there were more women than 
men, but the sex distribution did not differ significantly 
between patients with and without dementia (p=0.241). 
The level of education did not differ significantly between 
the two groups (p=0.314). As expected, the mean MMSE 
score was significantly higher in the group of individuals 
without dementia (p<0.0001). 
In the group of individuals with dementia 16/17 were 
classified as Codex category D, and only one as Codex 
category Β (this represents a negative result when the 
disease is present, i.e., a false negative result). In the group 
of individuals without dementia 11/27 were classified in 
Codex category Α, 13/27 in Codex category Β and 3/27 in 
Codex category D (the latter is a positive result when the 
disease is not present, i.e., a false positive result) (tab. 2). 
The sensitivity of a test shows its ability to detect a 
disease when it is present and for the Greek version of 
Codex it was calculated as the percentage of true positive 
results out of the total number of patients with dementia 
(16/17), i.e., 94.1%.
The specificity of a test shows its ability to exclude a 
disease when it is not present. In this case it was calculated 
as the percentage of true negative results out of the total 
number of patients without dementia (24/27), i.e., 88.9%.
The positive predictive value of the Greek version of 
Codex was calculated as the percentage of true positive out 
of the total number of positive results (16/19), i.e., 84.2%. 
The negative predictive value of the test was calculated as 
the percentage of true negative out of the total number of 
negative results (24/25), i.e., 96%.
A comparison between the results of Codex and MMSE 
in the study patients is depicted in table 3. The score on 
MMSE was available in 41 patients (missing in 3). From 
these data, it appears that there is equivalence between 
the results of Codex and MMSE. Even though the numbers 
are small, these findings imply that Codex may have higher 
sensitivity and lower specificity than MMSE. In 5 individu-
als for whom the test Codex was positive, but who did not 
fulfill the criteria for dementia, the MMSE score was ≥24 
(negative). Specifically, the MMSE scores of these 5 patients 
ranged between 25 and 27. 
DISCUSSION
The general practitioner (GP) plays an important role in 
the investigation and management of people with cogni-
tive disorders. The diagnosis of dementia is often made a 
considerable time after the onset of symptoms. GPs often 
have difficulty in recognizing dementia in the early stages 
Table 2. Cognitive Disorders Examination (Codex) diagnostic categories 
in patients with and without dementia.
Group of patients Codex category n Result
Patients with dementia A 0 FN
B 1 FN
C 0 TP
D 16 TP
Subtotal 17
Patients without dementia A 11 TN
B 13 TN
C 0 FP
D 3 FP
Subtotal 27
Total 44
TP: True positive, TN: True negative, FP: False positive, FN: False negative
Table 3. Comparison between the results of the Mini Mental State Ex-
amination (MMSE) and Cognitive Disorders Examination (Codex) in 44 
older people with and without dementia.
MMSE score MMSE <24
(positive for 
dementia)
(n)
MMSE ≥24
(negative for 
dementia)
(n)
Codex category n
Codex negative (categories Α and Β) 1 22
Codex positive (categories C and D) 13 5
Group of patients
Patients without dementia 0 25
Patients with dementia 14 2
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and they do not always comply with the guidelines for the 
management of dementia.19 The main reasons for this are 
the limited time available for consultation in the primary 
care setting, a lack of relevant knowledge and appropriate 
education,20 the attitude of doctors towards the diagnosis 
of dementia,21 and the interaction between the complex-
ity of the case and time pressures.22 A systematic review 
showed that there are significant differences among GPs 
regarding practices in diagnosing and managing dementia. 
The percentage of doctors who examined cognitive func-
tions based on a validated diagnostic tool varied from 4% 
to 96%, depending on the study. More recently published 
studies indicate a shift in care practices, with an increase in 
intervention and specialist referral for dementia.23 A recent 
clinical trial in Australia aims to improve the education 
of GPs in the diagnosis and management of dementia in 
primary care.24
The question of whether older people should be 
screened for dementia is a topic of debate.25 On the one 
hand, diagnosing dementia in its early stages has certain 
advantages: It enables the recognition of reversible causes 
of dementia and the timely onset of treatment aimed at 
delaying the progress of the disease, either with medica-
tion or with non-pharmacological methods, and provides 
the opportunity for planning the legal regulations that 
will be needed when the person no longer has the men-
tal capacity to make decisions. On the other hand, the 
recognized criteria for mass screening are not fulfilled, as 
there is insufficient evidence that the implementation of 
screening has improved the outcome of the disease, and 
cost-effectiveness has not been proven. The gravity of the 
psychological cost and iatrogenic complications of an er-
roneous diagnosis in case of a false positive result should 
not be overlooked. For the above reasons, guidelines do 
not recommend screening of the general population for 
dementia.26 The identification of individuals with dementia 
(case finding) appears to be a more suitable approach.22
The patient who presents at the GP surgery with re-
ported memory loss should be examined in order to ex-
clude or confirm an objective decline of memory or other 
cognitive functions. In many cases the individual is not 
aware of or does not complain about memory loss, but 
behavior changes are noticed by relatives. Such changes 
may be related to memory (e.g., the individual forgets to 
take medication, forgets to attend an important meeting, 
does not remember which day of the week it is, etc.) or other 
cognitive functions (e.g., neglect of personal hygiene, avoid-
ance of complex cooking recipes, etc.). In such cases the 
GP is expected to recognize and investigate the symptoms. 
Codex has been validated in French as a useful tool for 
the rapid detection of dementia.18 It has also been shown 
that an abnormal Codex result in patients without known 
dementia before surgical repair of hip fracture is associated 
with postoperative delirium.27
This study was conducted as a first attempt to imple-
ment Codex in the Greek language and in the Greek popu-
lation, in the context of primary care. The advantages of 
the test are its short duration (3 minutes) and ease of 
administration. According to these preliminary findings, 
the sensitivity of Codex in the detection of dementia is 
high (94.1%) and its specificity is also good (88.9%). It has 
also satisfactory positive predictive value (84.2%) and a 
high negative predictive value (96%). These findings are 
encouraging and show that the Greek translation of Codex 
may be used effectively in the Greek population.
In addition, comparison between the results of the 
Greek versions of Codex and MMSE showed that there 
is equivalence between the two tests. Despite the small 
size of the sample, the findings indicate that Codex may 
have higher sensitivity and lower specificity than MMSE. 
The individuals for whom the Codex result was positive, 
but who did not fulfill the diagnostic criteria for dementia 
had MMSE scores between 25 and 27. It is of note that the 
median level of education in this group of patients was 
10 years; hence, these were people with a moderate to 
high level of education. This finding is consistent with the 
recommendation that the diagnostic threshold of MMSE 
should be adjusted to 27 (instead of 24) for people of a 
high educational level.28
The main limitation of the present study is the small 
sample of patients. In order to validate Codex as a diagnostic 
tool in the Greek population, the study of a larger number 
of individuals is required, using rigorous methodology, in-
cluding re-testing, inter-rater variability, and the definition 
of thresholds for positive and negative results.
This study, however, accomplished its main objective, 
which was the validation of the translation of Codex into 
the Greek language. Under the current extremely adverse 
financial circumstances in Greece, the familiarization of GPs 
with simple diagnostic tools for dementia can significantly 
help the elderly, a vulnerable group of people who are 
particularly affected by the financial crisis.
In conclusion, Codex is an easy, reliable and rapid test 
for the detection of dementia in the primary care setting. 
Use of the Greek version of Codex has provided the first 
encouraging results that can lead to its implementation in 
the Greek population after a larger validation study.
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για την ανίχνευση της άνοιας στην πρωτοβάθμια φροντίδα υγείας
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ΣΚΟΠΟΣ Επικύρωση της ελληνικής μετάφρασης της δοκιμασίας Codex και διερεύνηση της δυνατότητας εφαρμο-
γής της για την ανίχνευση της άνοιας στον ελληνικό πληθυσμό. ΥΛΙΚΟ-ΜΕΘΟΔΟΣ Στη μελέτη έλαβαν μέρος ασθε-
νείς με άνοια και άτομα που δεν έπασχαν από άνοια (με βάση τα διαγνωστικά κριτήρια DSM-IV-TR), ηλικίας >60 ετών. 
Έγινε μετάφραση της δοκιμασίας Codex από τα Γαλλικά στα Ελληνικά και στη συνέχεια, αντίστροφα, από τα Ελληνι-
κά στα Γαλλικά για τον έλεγχο της εγκυρότητας της μετάφρασης. Όλοι οι ασθενείς (με άνοια ή χωρίς) εξετάστηκαν με 
την ελληνική έκδοση του Codex και του Mini Mental State Examination (MMSE). ΑΠΟΤΕΛΕΣΜΑΤΑ Συνολικά, εξετά-
στηκαν 44 άτομα (17 με άνοια και 27 χωρίς άνοια). Η διάμεση ηλικία ήταν τα 82 έτη (εύρος: 61–93) για τους ασθενείς 
με άνοια και τα 73 έτη (εύρος: 61–84) για τους ασθενείς χωρίς άνοια. Τα έτη εκπαίδευσης ήταν κατά μέσο όρο 9 (εύ-
ρος: 2–20) για τους ασθενείς με άνοια και 10,5 (εύρος: 3–16) για τους ασθενείς χωρίς άνοια. Η βαθμολογία στο MMSE 
ήταν κατά μέσο όρο 15,7 (εύρος: 7–27) για τους ασθενείς με άνοια και 28,3 (εύρος: 25–30) για την ομάδα ελέγχου. Η 
ευαισθησία της δοκιμασίας Codex για τη διάγνωση της άνοιας ήταν 94,1% και η ειδικότητά της ήταν 88,9%. ΣΥΜΠΕ-
ΡΑΣΜΑΤΑ Η μετάφραση της δοκιμασίας Codex στα Ελληνικά έδωσε αξιόπιστα αποτελέσματα ως προς τη διάγνωση 
της άνοιας. Για την επικύρωσή της ως διαγνωστικού οργάνου στον ελληνικό πληθυσμό απαιτείται μελέτη μεγαλύτε-
ρου δείγματος ασθενών. 
Λέξεις ευρετηρίου: Άνοια, Γνωστική δυσλειτουργία, Codex (Cognitive Disorders Examination), Πρωτοβάθμια φροντίδα υγείας
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APPENDIX 1. Greek version of the Cognitive Disorders Examination (Codex).
Δοκιμασία CODEX – Φύλλο 1
COgnitive Disorders EXamination
Όνομα ασθενούς: ............................................................................................................................................................
Ημερομηνία: ............../............../..............
Πρώτο στάδιο:
Θα σας πω τρεις λέξεις. Σας παρακαλώ να τις επαναλάβετε μετά από μένα. Οι λέξεις είναι:
??Λεμόνι
??Κλειδί
??Μολύβι
«Σας ζητώ να τις κρατήσετε στη μνήμη σας, γιατί θα σας τις ζητήσω αμέσως μετά».
Δώστε στο άτομο ένα μολύβι και ένα φύλλο χαρτί στο οποίο είναι τυπωμένος ένας κύκλος διαμέτρου περίπου 10 cm (φύλλο 2).
 «Αυτός ο κύκλος αντιπροσωπεύει το καντράν ενός ρολογιού χειρός ή ενός ρολογιού τοίχου. Σας παρακαλώ να 
γράψετε τους αριθμούς που βλέπουμε πάνω στο καντράν». Να προσέξετε το άτομο να μη χρησιμοποιήσει πρότυπο (ρολόι 
χειρός, ρολόι τοίχου).
Όταν το άτομο έχει τελειώσει: «Τώρα σας παρακαλώ να σχεδιάσετε τους δείκτες, με τρόπο που να αντιπροσωπεύουν 
την ακόλουθη ώρα:...............» (ο εξεταστής υποδεικνύει την ώρα της επιλογής του. Σημειώνει την ώρα που ζητήθηκε:  [__I__I 
[__I__]).
Όταν το άτομο έχει τελειώσει: «Σας παρακαλώ να μου πείτε τις 3 λέξεις που σας ζήτησα να συγκρατήσετε». (αξιολόγηση) 
Αξιολόγηση του πρώτου σταδίου (κυκλώστε τις απαντήσεις):? 3 λέξεις: Ανακλήθηκαν όλες: ΝΑΙ = φυσιολογικό
 ΟΧΙ = μη φυσιολογικό? Ρολόι: Οι αριθμοί είναι όλοι παρόντες = ΝΑΙ – ΟΧΙ
 Η θέση τους είναι σωστή κατά προσέγγιση = ΝΑΙ – ΟΧΙ
 Η κατεύθυνση των δεικτών υποδεικνύει κατά προσέγγιση την ώρα που ζητήθηκε = ΝΑΙ – ΟΧΙ
Μπορούμε να διακρίνουμε τον μικρό και τον μεγάλο δείκτη = ΝΑΙ – ΟΧΙ
4 ΝΑΙ = φυσιολογικό
Σε κάθε άλλη περίπτωση = μη φυσιολογικό
Οδηγίες διεξαγωγής του δεύτερου σταδίου: 
Θέσετε τις ακόλουθες ερωτήσεις, μία προς μία. Περιμένετε την απάντηση πριν να περάσετε στην επόμενη ερώτηση.
«Ποιο είναι το όνομα του νοσοκομείου όπου βρισκόμαστε*;» [__]
«Σε ποια πόλη είμαστε;» [__]
«Σε ποιο νομό είμαστε;» [__]
«Σε ποια περιοχή είμαστε;» [__]
«Σε ποιον όροφο είμαστε;» [__]
*Στην πόλη: Ποιο είναι το όνομα του δρόμου του ιατρείου; 
Αξιολόγηση του δεύτερου σταδίου:
1 βαθμός για κάθε σωστή απάντηση Άθροισμα =  [__]
Συμπέρασμα της δοκιμασίας CODEX: Βλέπε δέντρο απόφασης. 
Ερμηνεία
CODEX μη φυσιολογικό: Υψηλή πιθανότητα άνοιας. Θεωρήστε πιθανή τη διάγνωση της άνοιας. Παραπέμψετε τον 
ασθενή σε έναν ειδικό για την άνοια.
CODEX φυσιολογικό: Χαμηλή πιθανότητα άνοιας. Θεωρήστε πιθανές άλλες διαγνώσεις. Παρακολουθήστε τον ασθενή.
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Δοκιμασία CODEX – Φύλλο 2
COgnitive Disorders EXamination
Όνομα ασθενούς: …………………………………………..
Ημερομηνία: ………./……/……..  
...................................................................................................................................................
APPENDIX 2. Decision tree for the administration and interpretation of the Greek version of the Cognitive Disorders 
Examination (Codex).
